NCT03841175View on ClinicalTrials.gov

Forecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers

CompletedOBSERVATIONAL
Enrollment

477

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

August 1, 2018

Study Completion Date

August 1, 2018

Conditions
Cancer of Head and Neck
Trial Locations (1)

29609

CHRU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT03841175 - Forecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers | Biotech Hunter | Biotech Hunter